Over $80 Million in USDC Awaits Migration to Injective, Injective Says

More than $80 million in USD Coin (USDC) is awaiting migration to Injective, according to an announcement by the Injective network, which also disclosed that a $68 million portion tied to dYdX remains subject to a governance vote. The figure is a self-reported one, disclosed by the party that stands to benefit from the migration, and no independent on-chain audit accompanies the claim.

The split is concrete. Cosmos Hub has completed its treasury move to Injective-issued USDC, according to Injective's statement. The larger dYdX allocation of $68 million has not moved; it awaits the outcome of a vote by dYdX token holders.

Injective framed the milestone as a network-standard shift. The project described USDC on its chain as becoming a common standard for Cosmos and for dYdX. That is an aspiration as much as a fact: one completed treasury migration and one pending proposal do not yet constitute a standard, however the votes land.

What would the dYdX v9.9 upgrade change?

The dYdX Foundation has proposed a v9.9 software upgrade that would shift USDC backing on dYdX Chain from Noble, the Cosmos-native issuer, to Injective. The mechanics matter for users holding positions on the exchange.

According to the proposal as described by Injective, the upgrade would:

• introduce a Canonical USDC module on dYdX Chain;
• progressively substitute Injective-issued USDC for Noble's backing;
• preserve the existing token identifier and all account balances.

In plain words, a trader on dYdX should see no change in their wallet display; only the chain supplying the collateral behind that display would change. That is the promise. Whether the substitution executes without disruption to redemptions or bridging will only be verifiable once the upgrade ships.

Injective separately cited dYdX's monthly trading volume of more than $1 billion as context for the stakes. That volume figure, roughly $12 billion annualized if sustained, makes dYdX the largest single venue in this migration story, and it explains why the foundation is staging the change through governance rather than an administrative switch.

What remains unsaid?

The announcement is silent on several points a skeptical reader would want answered. There is no stated timeline for the v9.9 vote's close, no breakdown of the $80 million beyond the $68 million dYdX share, and no detail on fees, liquidity provisioning or redemption arrangements between Noble and Injective.

Noble, the incumbent issuer losing the dYdX mandate if the vote passes, has not commented in the materials released. Its continued role in the broader Cosmos ecosystem is a variable the announcement does not address.

There is also a concentration question. Moving both the Cosmos Hub treasury and, potentially, dYdX's collateral base onto Injective-issued USDC ties two major Cosmos economies to a single issuing pathway. Diversification arguments cut both ways, and the proposal documents do not engage with them.

What happens next?

The decisive event is the dYdX governance vote on v9.9. Approval would trigger the phased replacement of Noble-backed USDC with Injective-issued USDC on dYdX Chain, with token identifiers and balances intact by design.

Rejection would leave more than $68 million of the announced $80 million where it sits. Until the vote closes, the headline number describes intent, not a completed migration, and observers should treat it accordingly.